Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923415 · ClinicalTrials.gov registry record
A Non-drug Study Profiling Cutaneous Lupus
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 29
- Enrollment target
NCT01923415: Completed study, sponsored by Janssen Research & Development.
NCT01923415 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01923415 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the clinical and molecular profiles of patients with cutaneous lupus.
Primary Outcome
Investigation of pathways which may be dysregulated in cutaneous lupus lesions.
Interventions
- PROCEDURE No intervention, skin biopsy
- PROCEDURE No intervention, blood collection
- PROCEDURE No intervention, urine collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-08 |
What the finished NCT01923415 record still lists
NCT01923415 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which No intervention, skin biopsy is the first listed.
NCT01923415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01923415 about?
NCT01923415 is a clinical study titled "A Non-drug Study Profiling Cutaneous Lupus". The purpose of this study is to characterize the clinical and molecular profiles of patients with cutaneous lupus.
What is the current status of trial NCT01923415?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2013-04. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01923415?
The interventions under investigation include: No intervention, skin biopsy (PROCEDURE), No intervention, blood collection (PROCEDURE), No intervention, urine collection (PROCEDURE).
Who is sponsoring clinical trial NCT01923415?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia